40258-80-8 Usage
Ester
Derived from pivalic acid and 1-chloroethanol Indicates the functional group present in the compound, formed by the reaction between an acid and an alcohol.
Physical state
Colorless liquid Describes the appearance and state of the compound at room temperature.
Odor
Fruity Describes the smell of the compound, reminiscent of fruit.
Applications
a. Chemical intermediate Used in the production of pharmaceuticals and pesticides.
b. Solvent Utilized as a dissolving agent for various substances.
c. Raw material in organic synthesis Serves as a starting material for the synthesis of other organic compounds.
Hazardous substance
Potential health and safety risks Highlights the need for careful handling due to its potential to cause harm.
Skin and eye irritation
Can cause irritation Points out the compound's potential to cause discomfort or damage to the skin and eyes upon contact.
Flammable
Susceptible to ignition and combustion Emphasizes the need for caution when handling the compound due to its propensity to catch fire and burn.
Check Digit Verification of cas no
The CAS Registry Mumber 40258-80-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,2,5 and 8 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 40258-80:
(7*4)+(6*0)+(5*2)+(4*5)+(3*8)+(2*8)+(1*0)=98
98 % 10 = 8
So 40258-80-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H13ClO2/c1-5(8)10-6(9)7(2,3)4/h5H,1-4H3
40258-80-8Relevant articles and documents
N-substituted imidazole carboxylate compound, preparation method and medical uses thereof
-
Paragraph 0107-0111, (2017/12/13)
The present invention relates to a compound represented by a general formula (I) or a stereoisomer, a solvate, a pharmaceutically acceptable salt or a eutectic, a composition, a preparation method and medical uses thereof, wherein the general formula (I) is defined in the specification, and each substituent is defined in the specification.
COMPOUNDS AND THERAPEUTIC USES THEREOF
-
Paragraph 00312-00313; 00322, (2014/01/17)
The invention relates to compounds, pharmaceutical compositions and methods useful for treating cancer, systemic or chronic inflammation, rheumatoid arthritis, diabetes, obesity, T-cell mediated autoimmune disease, ischemia, and other complications associated with these diseases and disorders.
PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE
-
Page/Page column 99, (2011/02/26)
The invention relates to prodrugs of fused heterocyclic inhibitors of D-amino oxidase (DAAO) and methods of treating diseases and conditions, wherein modulation of D-amino acid oxidase activity, D-serine levels, D-serine oxidative products and NMDA receptor activity in the nervous system of a mammalian subject is effective.
